Import Tax Waivers As China Slowly Reopens Amid Virus Battle
Scrip Visits Dedicated Beijing Facility
Executive Summary
Import taxes waived for diagnostic testing agents for new virus, as China pharma sector faces uncertainty over extended holiday and potential disruptions to manufacturing and supplies.You may also be interested in...
Coronavirus Notebook: Regeneron, HHS To Develop Antibody
Wuhan Institute of Pathology files patent over new use of Gilead's remdesivir and Regeneron expands collaboration with HHS to include 2019-nCoV.
Coronavirus Notebook: China Generic Antiviral Filed For Emergency Approval
China is tightening oversight over suspected coronavirus cases, allowing hospitals to quarantine patients upon their first visit as confirmed infections surpass 20,000. Domestic firm Ascletis has meanwhile filed for the emergency approval of its generic version of AbbVie's Norvir (ritonavir) and a novel combo therapy.
Gilead Joins Coronavirus Fray With Repurposed Antiviral
US antiviral specialist Gilead is working to provide its experimental drug remdesivir to treat the China coronavirus, while other potential treatments and alliances continue to emerge, including between Wuhan-based BravoVax and US venture GeoVax.
Need a specific report? 1000+ reports available
Buy Reports